Contact: NCI Office of Media Relations
NIH/National Cancer Institute
Caption: A study of daughters of women given diethylstilbestrol, synthetic estrogen, during pregnancy has found that exposure to the drug while in the womb is associated with many reproductive problems and an increased risk of certain cancers. This chart includes the risks associated with DES exposure, compared to the risks for women who were not exposed to DES in the womb.
Credit: Image courtesy of the National Cancer Institute
Usage Restrictions: None
Related news release: Women exposed to diethylstilbestrol in the womb face increased cancer risk